255 related articles for article (PubMed ID: 8098843)
1. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
2. Role of the conserved C-terminal region of thyroid hormone receptor-alpha in ligand-dependent transcriptional activation.
Selmi-Ruby S; Casanova J; Malhotra S; Roussett B; Raaka BM; Samuels HH
Mol Cell Endocrinol; 1998 Mar; 138(1-2):105-14. PubMed ID: 9685219
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.
Saatcioglu F; Lopez G; West BL; Zandi E; Feng W; Lu H; Esmaili A; Apriletti JW; Kushner PJ; Baxter JD; Karin M
Mol Cell Biol; 1997 Aug; 17(8):4687-95. PubMed ID: 9234725
[TBL] [Abstract][Full Text] [Related]
4. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
Rascle A; Ferrand N; Gandrillon O; Samarut J
Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
Selmi S; Samuels HH
J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
[TBL] [Abstract][Full Text] [Related]
6. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
Schroeder C; Gibson L; Zenke M; Beug H
Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
[TBL] [Abstract][Full Text] [Related]
7. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
Zenke M; Muñoz A; Sap J; Vennström B; Beug H
Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.
Bigler J; Hokanson W; Eisenman RN
Mol Cell Biol; 1992 May; 12(5):2406-17. PubMed ID: 1314955
[TBL] [Abstract][Full Text] [Related]
9. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M
Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217
[TBL] [Abstract][Full Text] [Related]
10. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.
Baniahmad A; Köhne AC; Renkawitz R
EMBO J; 1992 Mar; 11(3):1015-23. PubMed ID: 1347744
[TBL] [Abstract][Full Text] [Related]
11. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
Rascle A; Ghysdael J; Samarut J
Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a cDNA encoding human Rev-ErbA alpha: transcription from the noncoding DNA strand of a thyroid hormone receptor gene results in a related protein that does not bind thyroid hormone.
Lazar MA; Jones KE; Chin WW
DNA Cell Biol; 1990 Mar; 9(2):77-83. PubMed ID: 1971514
[TBL] [Abstract][Full Text] [Related]
13. The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.
de Verneuil H; Metzger D
Nucleic Acids Res; 1990 Aug; 18(15):4489-97. PubMed ID: 1975094
[TBL] [Abstract][Full Text] [Related]
14. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.
Barettino D; Bugge TH; Bartunek P; Vivanco Ruiz MD; Sonntag-Buck V; Beug H; Zenke M; Stunnenberg HG
EMBO J; 1993 Apr; 12(4):1343-54. PubMed ID: 8096810
[TBL] [Abstract][Full Text] [Related]
15. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
[TBL] [Abstract][Full Text] [Related]
16. A novel cis element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation.
Saatcioglu F; Deng T; Karin M
Cell; 1993 Dec; 75(6):1095-105. PubMed ID: 7903219
[TBL] [Abstract][Full Text] [Related]
17. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
Schroeder C; Gibson L; Beug H
Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
[TBL] [Abstract][Full Text] [Related]
18. The thyroid hormone receptor interferes with transcriptional activation via the AP-1 complex.
Schmidt ED; Cramer SJ; Offringa R
Biochem Biophys Res Commun; 1993 Apr; 192(1):151-60. PubMed ID: 8386506
[TBL] [Abstract][Full Text] [Related]
19. Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA.
Yen PM; Ikeda M; Brubaker JH; Forgione M; Sugawara A; Chin WW
J Biol Chem; 1994 Jan; 269(2):903-9. PubMed ID: 7904604
[TBL] [Abstract][Full Text] [Related]
20. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
Damm K; Evans RM
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
